About Us

Our mission is to redefine the way the brain is measured and treated to optimise patient outcomes across the care continuum.

CoMind is a team of highly skilled and passionate individuals working towards the development of innovative neuromonitoring devices and neural interfaces.

Through the technology we are building, doctors will gain access to a huge range of critical neurophysiological signals, many of which are inaccessible today, in a single, simple, non-invasive measurement at the patient’s bedside.

The Team

Leading experts with a proven track record of developing and commercialising products globally.

James Dacombe Founder, Chief Executive Officer and Chairman
Simon Morling Chief Operating Officer
Dr. Rob Cooper Chief Scientific Officer
Chema Garcia-Soto, MBA Chief Commercial Officer
Kevin Walsh Chief Financial Officer
Dr. Marc Bloom Chief Medical Officer
Morgan Lockyer Chief of Staff
Dr. Dawid Borycki Principal Engineer
Clinical Advisory Board

The Clinical Advisory Board is composed of distinguished experts in the fields of neurology, neurosurgery, anesthesiology and critical care. These leaders bring decades of experience and provide independent, broad-scope scientific and clinical guidance. 

 

Dr. Ramani Balu, MD Clinical Advisory Board Member
Dr. Howard Riina, MD Clinical Advisory Board Member
Prof. Chris A Troianos Clinical Advisory Board Member
Mary Kay Bader Clinical Advisory Board Member
Prof. Andrew Kofke Clinical Advisory Board Member
Dr. David Segar Clinical Advisory Board Member

Careers

Help us advance neurosensing for brain disorder patients globally

Learn more